Pfizer Inc (NYSE:PFE) maintains global operations across medicines and vaccines, delivering consistent earnings, operational ...

Two years into the pandemic, COVID-19’s potential to fuel domestic drug manufacturing hasn’t faded. Take Pfizer’s new $120 million investment, for example. The company on Monday said it’s plugging the ...

After beefing up the target of its global cost-savings drive once again, Pfizer is continuing to see its plan through with cuts in numerous countries. | As part of a multi-year cost-cutting initiative ...

Drug giant Pfizer is informing hospitals that dozens of its products could face “continued or new supply disruptions in the near-term” after an EF-3 tornado last week severely damaged its plant in ...

Pfizer has entered into a global collaboration and license agreement with YaoPharma for the development, manufacturing and commercialization of YP05002, a small-molecule GLP-1 receptor agonist ...

Pfizer’s newest vaccine manufacturing site has history of mold, recall troubles The McPherson, Kan., facility slated to be used as a fill-and-finish site for Pfizer COVID-19 vaccines has a history of ...

About two years ago, Pfizer acquired Wyeth to create what it says is the world’s largest biopharmaceutical company offering products in a variety of therapeutic areas. Wyeth brought to the merger an ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today a multi-year collaboration with GSK on the development of a next-generation equipment design, building upon Pfizer’s existing portable ...

When the coronavirus pandemic began, the challenge for Pfizer and BioNTech wasn’t just developing a Covid-19 vaccine — they also had to make it, and by the hundreds of millions. This was no small feat ...

When the coronavirus pandemic began, the challenge for Pfizer and BioNTech wasn’t just developing a Covid-19 vaccine — they also had to make it, and by the hundreds of millions. This was no small feat ...